Dr Reddys Laboratories (RDY) Acquisitions (2015 - 2026)
Dr Reddys Laboratories (RDY) posted Acquisitions of -$2.3 million for Q2 2026, up 66.97% on a QoQ basis from -$7.0 million in Q3 2020.
Analysis
Dr Reddys Laboratories (RDY) Acquisitions (2015 - 2026) Analysis & Trends
Dr Reddys Laboratories has reported Acquisitions for 3 years, with the latest figure at -$2.3 million in Q2 2026.
- On a quarterly basis, Acquisitions changed N/A year-over-year to -$2.3 million in Q2 2026; TTM through Jun 2026 was -$9.4 million, a N/A change from a year earlier, with the FY2026 full-year figure at -$34.0 million, up 94.53% from the prior year.
- Acquisitions was -$2.3 million for Q2 2026 at Dr Reddys Laboratories, up from -$7.0 million in the prior quarter.
- The five-year high for Acquisitions was -$2.3 million in Q2 2026, with the low at -$2.3 million in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | -2.32 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.32 Mn |
| Sep 30, 2020 | -7.04 Mn |
| Jun 30, 2020 | -197.13 Mn |
| Jun 30, 2015 | -125.31 Mn |